CSL

MTPConnect has launched a $28.5M Accelerator backing home-grown start-up Innovations for Heart Disease and Diabetes and CSL is a proud partner.   Professor Bronwyn Kingwell, Research Portfolio Strategy and Therapeutic Area Lead at CSL says our support of this research commercialisation Accelerator dovetails nicely with our long-term commitment to supporting Australia’s biotech ecosystem. “With the Accelerator’s support, we hope to see increased therapeutic development in cardiovascular disease and diabetes to benefit patients in Australia and around the world,” she said. #CSL

We are thrilled to announce the opening of our new state-of-the-art Multicube manufacturing facility in St. Gallen, Switzerland! With a modular design that can grow cube by cube and cutting-edge sustainability features like heat recovery and on-site solar power, we're set to meet the rising global demand for iron-based therapies. Discover how we're innovating for a healthier, more sustainable future. Watch the video and read more! https://bit.ly/47gJaUS #CSLVifor #Innovation #Sustainability #Healthcare #IronTherapies

September is National Sickle Cell Awareness Month in the U.S., a time to raise awareness of this blood disease. Millions of people carry the sickle cell trait without showing symptoms, so awareness and testing are crucial. #NationalSickleCellAwarenessMonth

As a rare condition, understanding the root cause of Hereditary Angioedema (#HAE) is crucial for improving patient management and care. On the latest #HAESpeaks podcast from Hereditary Angioedema Association - HAEA, doctors Raffi Tachdjian and Jay Kashkin dive deep into the critical role of factor XIIa on the HAE pathway. To further your understanding of the condition, listen here: https://bit.ly/3Z8JYJe

At CSL, we believe that when our employees thrive, our entire CSL family flourishes. Explore a wealth of career and development tools, a global employee share plan, study assistance, and more. Plus, enjoy access to our in-office gyms, where our team can stay active and energized, like in this boxing session! #PromisingFutures #CSL Learn more about how we support your well-being: https://bit.ly/3XsgRzm

When you join our team at CSL, you become part of a culture where empowerment fuels innovation. At CSL, we believe in empowering our employees to take initiative, driving excellence in everything we do. #PromisingFutures #CSL Explore our careers: https://bit.ly/3TxWte7

What do you get when you bring together three experts in public health, vaccines, and manufacturing and add a new vaccine manufacturing site? Some terrific conversations about influenza, pandemic preparedness, and CSL’s technical capabilities in Australia. We welcomed the Australian Government Department of Health and Aged Care's Chief Medical Officer and Head of the interim Australian CDC, Professor Paul Kelly to the CSL Seqirus Tullamarine facility that will provide onshore production capacity for antivenoms for Australia and cell-based influenza vaccines for Australia and the world. #CSL #CSLSeqirus #Tullamarine #Australia #publichealth #vaccines #influenza #DrivenByOurPromise

Vaccination for #influenza reduces the risk of severe disease. The Centers for Disease Control and Prevention (CDC) is focused on educating people about the importance of staying up to date on the latest vaccinations. During National Immunization Awareness Month, CSL joins the #CDC in encouraging people to speak with their healthcare providers about the vaccinations that are right for people of all ages. Learn more about CSL: https://bit.ly/3Z4cdsB #CSLSeqirus #CSL #DrivenByOurPromise #NIAM

CSL makes infused medicines that need to be stored at the right temperature. We recently offered patients these tips from the Immune Deficiency Foundation. https://bit.ly/3Z4bZ4F

We're thrilled to announce CSL's Global HQ and Centre for Research & Development in Melbourne, Australia has achieved 5 Star Green Star certification, representing Australian excellence in better, healthier and more responsible buildings. Our sustainable design initiatives included planning for longevity, dematerialisation, energy and water efficiencies and onsite energy generation. In addition, biophilic design, waste minimisation and prioritisation of local materials with an emphasis on nontoxic, renewable and recyclable products were key to the approach. We thank our many partners who have helped bring this building to life. For the 850 people who work across the 16 levels, whether in lab coats or on laptops, it's more than just a building; it's a where we connect, collaborate, and deliver for our patients. www.csl.com #CSL